Welcome to the Week in Review.

1. Biden Promises to Expand The Inflation Reduction Act

2. Exposing Big Pharma Lies

3. Medicare Negotiation Puts Patients Over Profit

BONUS: A new study from Bentley University shows that the National Institutes of Health (NIH) invested $11.7 billion on research leading to the approval of the first 10 drugs up for Medicare negotiation. Lower negotiated drug prices will help ensure patients and taxpayers get a better deal on these widely-used, high-cost medications. We deserve a fair return on the drugs taxpayers paid to invent!

Have a great weekend!